Absorbed dose distribution of the Auger emitters 67Ga and 125I and the β-emitters 67Cu, 90Y, 131I, and 186Re as a function of tumor size, uptake, and intracellular distribution

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 1, 1996, Pages 197-204

  Van Dieren, E B ^a   Plaizier, M A B D ^a   Van Lingen, A ^a   Roos, J C ^a   Barendsen, G W ^a   Teule, G J J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Crossfire; Dosimetry; Metastases; Radionuclides; Selectivity

Indexed keywords

COPPER 67; GALLIUM 67; IODINE 125; IODINE 131; RADIOISOTOPE; RHENIUM 186; YTTRIUM 90;

ARTICLE; CANCER MODEL; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; COMPUTER ANALYSIS; DOSIMETRY; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TUMOR VOLUME;

EID: 0029789267     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00280-5     Document Type: Article

References (38)

1. G.W. Barendsen Differences in radiosensitivity among cells in culture and in experimental tumors: Significance for the effectiveness of human cancer therapy Radiother. Oncol. 8 1987 285 300
2. M.J. Berger Energy deposition in water by photons from point isotropic sources J. Nucl. Med. Suppl 1 1968 17 25
3. 125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters Nature 265 1977 620 621
4. L.W. Brady C. Miyamoto D.V. Woo M. Rackover J. Emrich H. Bender S. Dadparvar Z. Steplewski H. Koprowski P. Black B. Lazzaro S. Nair J. McCormack J. Nieves M. Morabito J. Eshleman Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial Int. J. Radiat. Oncol. Biol. Phys. 22 1992 225 230
5. A. Cole Absorption of 20 eV to 50,000 eV electron beams in air and plastic Radiat. Res. 38 1969 7 33
6. 67Cu-BAT LYM-1 J. Nucl. Med. 34 1993 93P (abstr)
7. M.H. Griffith E.D. Yorke B.W. Wessels G.L. DeNardo W.P. Neacy Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy J. Nucl. Med. 29 1988 1795 1809
8. P.C. Huijgens A.R. Jonkhoff O.S. Hoekstra G.J. Ossenkoppele G.J.J. Teule Therapeutic potential of intraveneous 67-gallium in non-Hodgkin's lymphoma Eur. J. Haematol. 51 1993 206 208
9. C.A. Hoefnagels Anti-cancer radiopharmaceuticals Anti-Cancer Drugs 2 1991 107 132
10. K.G. Hofer Biophysical aspect of Auger processes Int. J. Radiat. Biol. 61 1992 289 292
11. R.W. Howell D.V. Rao Macroscopic dosimetry for radioimmunotherapy: Nonuniform activity distributions in solid tumors Med. Phys. 16 1989 66 74
12. R.W. Howell D.V. Rao D. Hou V.R. Narra K.S.R. Sastry The question of relative biological effectiveness and quality factor and Auger emitters incorporated into proliferating mammalian cells Radiat. Res. 128 1991 282 292
13. J.H. Hubbell Photon mass attenuation and energy-absorption coefficients for 1 keV to 20 MeV Int. J. Appl. Radiat. Isother. 33 1982 1269 1290
14. J.L. Humm Dosimetric aspects of radiolabelled antibodies for tumor therapy J. Nucl. Med. 27 1986 1490 1497
15. J.L. Humm L.M. Cobb Nonuniformity of tumor dose in radioimmunotherapy J. Nucl. Med. 31 1990 75083
16. R.K. Jain Haemodynamic and transport barriers to the treatment of solid tumors Int. J. Radiat. Biol. 60 1991 85 100
17. A.R. Jonkhoff E.B. van Dieren P.C. Huijgens R.T. Versteegh A. Dräger A.A. van den Loosdrecht G.J.J. Teule Biological effectness of 67-gallium decay in HL60 cells compared with external low dose rate gamma irradiation: Effects on proliferation, G2 arrest, and clonogenic capacity Int. J. Radiat. Oncol. Biol. Phys. 30 1994 117 124
18. V.K. Langmuir R.M. Sutherland Dosimetry models for radioimmunotherapy Med. Phys. 15 1988 867 873
19. P.K. Leichner C.S. Kwok Tumor dosimetry in radioimmunotherapy: Methods of calculation for β-particles Med. Phys. 29 1993 529 534
20. G.M. Makrigiorgos S.J. Adelstein A.I. Kassis Limitations of conventional dosimetry at the cellular level J. Nucl. Med. 30 1989 1856 1864
21. G.M. Makriogiorgos S.J. Adelstein A.I. Kassis Auger electron emitters: Insights gained from in vitro experiments Radiat. Environ. Biophys. 29 1990 75 91
22. Medical Internal Radiation Dose Committee Radionuclide data and decay schemes 1989 Society of Nuclear Medicine New York
23. W.T. Millar A. Barrett Dosimetric model for antibody targeted radionuclide therapy of tumor cells in the cerebrospinal fluid Cancer Research 50 1990 1043s 1048s (Suppl)
24. E.E. Watson M. Stabin Basic alternatives software package for internal radiation dose calculations R.L. Kathren D.P. Higby M.A. McKinney Computer applications in health physics: Proceedings of the 17th midyear topical symposium of the Health Physics Society 1984 HPS Richland, WA 4.29 4.48
25. R. Loevinger M. Berman MIRD pamphlet no. 1: A revised schema for calculating the absorbed dose from biologically distributed radionuclides 1976 Society of Nuclear Medicine New York
26. J.B. Mitchell E. Glatstein Radiation oncology: Past achievements and ongoing controversies Cancer Res. 51 1991 5065s 5073s (Suppl)
27. E. Pomplun J. Booz D.E. Charlton A Monte Carlo simulation of Auger cascades Radiat. Res. 111 1987 533 552
28. W.V. Prestwich J. Nunes C.S. Kwok Beta dose point kernels for radionuclides of potential use in radioimmunotherapy J. Nucl. Med. 30 1989 1036 1046
29. P.L. Robertson D.J. Buchsbaum D.B. Heidorn R.K. Ten Haken Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography Int. J. Radiat. Oncol. Biol. Phys. 24 1992 329 334
30. J.C. Roeske G.T.Y. Chen R.A. Atcher C. Pelizzari J. Rotmensch D. Haraf A. Montag R.R. Weichselbaum Modelling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with α- and β-emitters Int. J. Radiat. Oncol. Biol. Phys. 19 1990 1539 1548
31. M. Schlumberger M. Tubiana J.D. Piekarski C. Tubiana C. Parmentier Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays J. Nucl. Med. 29 1988 1790 1794
32. E.B. van Dieren A. van Lingen J.C. Roos G.J.J. Teule Validation of the histogram technique for three-dimensional and two-dimensional dosimetric calculations Appl. Radiat. Isother. 43 1992 1211 1221
33. E.B. van Dieren A. van Lingen J.C. Roos G.J.J. Teule The relevance of uptake and intracellular distribution for the dosimetry of Auger and β-emitting radionuclides and micrometastases Radiat. Protein Dosim. 52 1994 391 394
34. H.M. Vriesendorp H.M. Quadri R.L. Stinson O.C. Onyekwere M.S.Y. Shao J.L. Klein P.K. Leichner J.R. Williams Selection of reagents for human radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 22 1991 36 45
35. T.E. Wheldon J.A. O'Donogue The radiobiology of targeted radiotherapy Int. J. Radiat. Biol. 58 1990 1 21
36. 90Y Radiother. Oncol. 21 1991 91 99
37. L.E. Williams R.B. Duda R.T. Proffitt B.G. Beatty J.D. Beatty J.Y.C. Wong J.E. Shively R.J. Paxton Tumor uptake as a function of tumor mass: A mathematical model J. Nucl. Med. 29 1988 103 109
38. E.D. Yorke L.E. Williams A.J. Demidecki D.B. Heidorn P.L. Roberson B.W. Wessels Multicellular dosimetry for β-emitting radionuclides: Autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations Med. Phys. 20 1993 543 549